Sequence Variant in the LPIN1 gene in Patients with Metabolic Syndrome

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Objective: Metabolic syndrome (MetS) is a complex disease characterized by insulin resistance, abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low HDL-cholesterol level. The aim of the study was to evaluate the sequence variations in the LPIN1 gene in MetS. This gene codes lipin-1 protein which functions as Mg-dependent phosphatidic phosphatase enzyme and transcriptional coactivator. Material and Methods: The study groups included 73 MetS (19 M/54 F) and 56 non-MetS (16 M/40 F). Sequence variation in exons 2, 4, 5 and 14 of the LPIN1 gene were investigated by DNA sequencing method. Results: c.696 G>C variant (p.S232S) in exon 5 was observed in only one women with MetS. But this variation is not important because of coding same amino acid. Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/16115Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5505/tjb.2013.41033Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKural, Birgul Vanizor
dc.contributor.authorDeger, Orhan
dc.contributor.authorErem, Cihangir
dc.contributor.authorYücesan, Fulya Balaban
dc.contributor.authorBarlak, Yasam
dc.contributor.authorTuran, Ibrahim
dc.contributor.authorAliyazicioglu, Rezzan
dc.date.accessioned2026-10-22T10:26:26.389126148Z
dc.date.available2026-10-22T10:26:26.389126148Z
dc.date.issued2013
dc.description.abstractObjective: Metabolic syndrome (MetS) is a complex disease characterized by insulin resistance, abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low HDL-cholesterol level. The aim of the study was to evaluate the sequence variations in the LPIN1 gene in MetS. This gene codes lipin-1 protein which functions as Mg-dependent phosphatidic phosphatase enzyme and transcriptional coactivator. Material and Methods: The study groups included 73 MetS (19 M/54 F) and 56 non-MetS (16 M/40 F). Sequence variation in exons 2, 4, 5 and 14 of the LPIN1 gene were investigated by DNA sequencing method. Results: c.696 G>C variant (p.S232S) in exon 5 was observed in only one women with MetS. But this variation is not important because of coding same amino acid. Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.
dc.description.sponsorshipKaradeniz Technical University Research Fund [2006.114.001.2, 2003.114.003.5, 2008.114.001.12]
dc.identifier.doi10.5505/tjb.2013.41033
dc.identifier.eissn1303-829X
dc.identifier.endpage285
dc.identifier.issn0250-4685
dc.identifier.issue3
dc.identifier.startpage280
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/16115
dc.identifier.volume38
dc.identifier.wosWOS:000328162700006
dc.language.isoen
dc.publisherWALTER DE GRUYTER GMBH
dc.relation.ispartofTURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectmetabolic syndrome
dc.subjectLPIN1
dc.subjectlipin-1
dc.subject.classificationBiochemistry & Molecular Biology
dc.subject.otherINSULIN-RESISTANCE
dc.subject.otherLIPIN
dc.subject.otherASSOCIATION
dc.subject.otherPOLYMORPHISMS
dc.subject.otherBIOSYNTHESIS
dc.subject.otherOBESITY
dc.subject.otherFAMILY
dc.subject.otherROLES
dc.titleSequence Variant in the LPIN1 gene in Patients with Metabolic Syndrome
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex2
rdl.citation.trdizin1
rdl.citation.wos2
rdl.oa.statuspreprint
rdl.oa.statusgreen
rdl.oa.urlhttps://hdl.handle.net/11486/4520
rdl.sdgSDG03
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)